| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.08 |